BZ NOTE: The New England Journal Of Medicine Is Set To Release A Highly-Anticipated Study On The Effects Of Hydroxychloroquine At 5 p.m. Today; Watching Shares Of Mylan, Teva As Early Results Of The Study Have Been Published By Dow Jones
Benzinga Newsdesk